Insider Transactions in Q3 2022 at Metlife Inc (MET)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2022
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
98
+0.74%
|
$6,468
$66.41 P/Share
|
|
Sep 14
2022
|
Catherine R Kinney Director |
BUY
Grant, award, or other acquisition
|
Direct |
261
+0.47%
|
$17,226
$66.41 P/Share
|
|
Sep 14
2022
|
William E Kennard Director |
BUY
Grant, award, or other acquisition
|
Direct |
246
+0.74%
|
$16,236
$66.41 P/Share
|
|
Sep 14
2022
|
Edward J Kelly Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
205
+0.74%
|
$13,530
$66.41 P/Share
|
|
Sep 14
2022
|
David L Herzog Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.22%
|
$2,772
$66.41 P/Share
|
|
Sep 14
2022
|
Robert Glenn Hubbard Director |
BUY
Grant, award, or other acquisition
|
Direct |
544
+0.67%
|
$35,904
$66.41 P/Share
|
|
Sep 14
2022
|
Gerald L Hassell Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+0.45%
|
$7,722
$66.41 P/Share
|
|
Sep 14
2022
|
Cheryl W Grise Director |
BUY
Grant, award, or other acquisition
|
Direct |
528
+0.7%
|
$34,848
$66.41 P/Share
|
|
Aug 19
2022
|
Steven J Goulart EVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
4,060
-6.84%
|
$272,020
$67.6 P/Share
|
|
Aug 19
2022
|
Steven J Goulart EVP & Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,513
+8.5%
|
$170,903
$31.15 P/Share
|
|
Aug 19
2022
|
Marlene Debel EVP & Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
4,060
-6.84%
|
$272,020
$67.6 P/Share
|
|
Aug 19
2022
|
Marlene Debel EVP & Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,513
+8.5%
|
$170,903
$31.15 P/Share
|